New study exonerates refined grains

April 08, 2019

April 8, 2019 - Washington, DC - A new study published this week in Advances in Nutrition, a peer-reviewed medical journal from the American Society of Nutrition, boldly substantiates that refined grains have gotten a bad rap. Extensive analyses of the existing body of published studies show that refined grain consumption is not associated with any of the chronic diseases to which it usually is attributed. As a result, this study illustrates that current dietary recommendations to reduce refined grain consumption conflict with the substantial body of published scientific evidence.

The study encompassed 11 meta-analyses (including 32 publications with data from 24 distinct cohorts) and demonstrates that refined grains are not associated with increased disease risk and premature death.

"Quite simply, refined grains are not the bad guy," says study author, Glenn Gaesser, PhD, professor of exercise science and health promotion and director of the Healthy Lifestyles Research Center at Arizona State University. "Contrary to popular belief and current dietary guidance, refined grain intake is not associated with type 2 diabetes, cardiovascular disease, coronary heart disease, stroke, hypertension, cancer or death."

Gaesser theorizes that refined grains have developed a guilt-by-association reputation. He asserts, "While refined grains are frequently characterized as unhealthy, this can be attributed to their inclusion in a dietary pattern that contains foods that are the real culprits in the link between an unhealthy dietary pattern and increased risk of a number of chronic diseases." Specifically, this study found:Gaesser explains how our dietary guidance on refined grains became misguided. "The make-half-your-grains-whole recommendation from the U.S. Dietary Guidelines Advisory Committee was based largely on studies that focused on dietary patterns, not specific food groups. This Western dietary pattern - which includes red and processed meats, sugar-sweetened foods and beverages, French fries, high-fat dairy products, and refined grains--is linked to many chronic diseases. However, when analyzed as a distinct food group, refined grain consumption is not linked to chronic diseases or death."

"The important takeaway of this study is that consumers need to know their stuff before they cut," says Sylvia Klinger, a registered dietitian nutritionist who sits on the Scientific Advisory Board of the Grain Foods Foundation. "The make-half-your-grains-whole messaging has dominated. However, enriched grain messaging has been lost. Eliminating enriched grain products will result in nutrient shortfalls. Refined grain foods that have been enriched and/or fortified help to alleviate shortfalls including B-vitamins, folic acid, thiamin, niacin, riboflavin, and the mineral iron. For example, enriched grains are the largest contributor of folic acid in the American diet. This is key to preventing neural tube birth defects."

"At the end of the day, you can have your refined grains and eat them too," Klinger continues. "The most scientifically sound recommendation may be to just encourage increased consumption of whole grains without specific recommendations to reduce refined grain intake. In fact, consumers can enjoy up to six or seven servings per day of refined grains without increasing risk for coronary heart disease, type 2 diabetes, hypertension or premature death."
The new published study in Advances in Nutrition can be found here. Preparation of the manuscript of this study was supported in part by a grant from the Wheat Foods Council and Grain Foods Foundation.

For more information about the research findings, and to learn more about grain foods' role in a healthful diet, please visit

About Grain Foods Foundation

Formed in 2004, Grain Foods Foundation (GFF) is a group of thought leaders and advocates for all grain foods and believes everybody needs grain food to enjoy a happy and healthy life. Committed to nutrition education programming that is firmly rooted in science, GFF is a strong advocate for our members and a resource for consumers and the media who want to learn more about the role of grains in a well-balanced eating pattern. GFF offers research-based information and resources to members, partners, influencers, policymakers and consumers through a comprehensive communications campaign, conferences, webinars, research tools, social media and more. GFF is committed to bringing fact-based information and common sense to the consumer. For more information, visit

The Ginger Network

Related Diabetes Articles from Brightsurf:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to